RCGP Chair Professor Kamila Hawthorne has featured widely in the national press and broadcast media responding to the phased roll-out of Mounjaro prescriptions by NHS England in general practice. This will take place from now for patients who meet certain clinical criteria. To summarise: 🟦 Weight-loss medications have a lot of potential benefits for patients but shouldn’t be seen as a silver bullet. 🟦 GPs are concerned about the workload and training implications of the roll-out which is why the College is pleased this is a phased roll-out; as and when this is escalated, appropriate resourcing must follow. 🟦 It’s vital that the roll out of weight loss medications as a treatment for obesity does not come at the expense of other weight loss services. Professor Kamila Hawthorne said: “While we recognise the potential benefits of weight loss drugs being prescribed in line with NICE guidance, we know many GPs are concerned about the implications of the rollout of weight loss drugs ...